ASSEMBLY BIOSCIENCES, INC.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
ASMB$21.79+6.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
(a)Exhibits. The following exhibits are filed or furnished, as applicable, as part of this quarterly report on Form 10-Q:
| ExhibitNumber | Description of Document | FiledHerewith | Incorporatedby Referencefrom | Date | Number |
|---|---|---|---|---|---|
| 10.1# | 2026 Corporate Bonus Plan. | Form 8-K | 03/30/2026 | 10.1 | |
| 10.2# | Amendment No. 1 to Amended and Restated Employment Agreement, dated March 26, 2026, between Assembly Biosciences, Inc. and Jason A. Okazaki. | Form 8-K | 03/30/2026 | 10.2 | |
| 31.1 | Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | |||
| 31.2 | Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | |||
| 32.1* | Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | |||
| 32.2* | Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | |||
| 101.INS | Inline XBRL Instance Document-the instance document does not appear in the Interactive Data File as its XBRLtags are embedded within the Inline XBRL document | X | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | X | |||
| 104 | Cover page formatted as inline XBRL and contained in Exhibits 101 | X | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.